Delivery Order SPE2DB20D3104-SPE2DB25FV3L7

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,472.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of March 17, 2025 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $16,190.26, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award, valued at $1,400.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of September 26, 2023. This award is a delivery order and has a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $6,137.35, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 19, 2024. The award is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $3,844.15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S, with an ultimate completion date of October 11, 2023. The contract has a Firm Fixed Price pricing type and is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $17,897.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price arrangement and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $26,625.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product, with a completion date of June 3, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $5,609.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $5,463.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award, valued at $27,961.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of January 7, 2025. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV3L7
    Delivery Order

This federal contract award, valued at $5,272.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S, with an ultimate completion date of October 31, 2024. The contract has a Firm Fixed Price pricing type and was not designated with a set-aside.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:48 PM